PPARγ Agonists: Emergent Therapy in Endometriosis
Endometriosis is one of the major gynecological diseases of reproductive-age women. This disease is characterized by the presence of glands and stroma outside the uterine cavity. Several studies have shown the major role of inflammation, angiogenesis, adhesion and invasion, and apoptosis in endometr...
Main Authors: | Alexandre Vallée, Jean-Noël Vallée, Alain Le Blanche, Yves Lecarpentier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/6/543 |
Similar Items
-
PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01) -
Optimized Structure-based Methodology for Studying PPARγ Partial Agonists
by: Merilin Al Sharif, et al.
Published: (2018-03-01) -
Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
by: Yves Lecarpentier, et al.
Published: (2019-05-01) -
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
by: Carmen Ciavarella, et al.
Published: (2020-04-01) -
Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches
by: Alexandre Vallée, et al.
Published: (2018-04-01)